Breaking News

Braskem Signs Joint Development Agreement With Genomatica for Bio-Based Butadiene

December 11, 2013

Braskem and Genomatic have formed an agreement for the joint development of commercial process
technology to make bio-based butadiene from renewable feedstocks.
Braskem is the world's leading producer of biopolymers and the world's third largest producer of butadiene.

Under the agreement, Braskem anticipates providing significant funding
of Genomatica's development work over several years; will allocate
significant Braskem R&D resources; and fund the construction and
operation of pilot and demonstration-scale butadiene production plants
using the process. In return, Braskem will receive certain exclusive
license rights to use the resulting process technology in the Americas.
Genomatica will also receive fees and royalties for each licensed
commercial plant.

Related Knowledge Center:

blog comments powered by Disqus